Patient Quality of Recovery From Mastectomy With and Without PECS Block With Liposomal Bupivacaine

Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Observational
SUMMARY

This is a prospective observational study. Investigators want to understand post-operative recovery for patients undergoing mastectomy at NorthShore University HealthSystem. Some of these patients receive PECS blocks with Liposomal Bupivacaine and some do not receive a block. Investigators want to know whether patients who receive a block have better post operative recovery and pain control than patients who do not receive one. Investigators also want to understand whether PECS blocks with Liposomal Bupivacaine improves quality of recovery at 72 hours post operatively.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: t
View:

• Must be female Must be \>18 years old and \< 90 years old Must be able to consent in English or Spanish May or may not have breast cancer (prophylactic mastectomy) Must be undergoing unilateral or bilateral mastectomy of any type May choose to proceed with or without breast reconstruction

Locations
United States
Illinois
Evanston Hospital
RECRUITING
Evanston
Contact Information
Primary
Mary Turk
mturk@northshore.org
847-570-1184
Time Frame
Start Date: 2023-04-25
Estimated Completion Date: 2027-04
Participants
Target number of participants: 800
Treatments
PECS Block with Liposomal Bupivacaine
The patients in this cohort will undergo a PECS block with Liposomal Bupivacaine before their mastectomy. Patients will receive Liposomal Bupivacaine in combination with 0.25% Bupivacaine in a 1:1 mixture for the purpose of post-operative pain control.
No PECS block
The patients in cohort will not undergo a PECS block. Pain will be controlled in the usual fashion with IV and oral medications.
Related Therapeutic Areas
Sponsors
Leads: Endeavor Health

This content was sourced from clinicaltrials.gov